Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer

NCT01446458 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Pancreas
Cancer of the Pancreas
Neoplasms, Pancreatic
Pancreas Cancer
Pancreas Neoplasms

Interventions

DRUG: Modified FOLFIRINOX
RADIATION: Stereotactic Body Radiotherapy (SBRT)

Sponsor

Emory University